Two top traders offered a mixed bag of stocks, across several sectors, to help investors prepare for market turbulence in the week ahead.
Peter Costa, managing director at Eckhart and Company, likes Washington Mutual.
"If you look at the stock and you look at the dividend it pays, even if they cut the dividend, the stock will more than likely pay more than 5 percent," he told CNBC. "I still think that stock has some room on the upside."
Dillards gets praises from Jon Najarian, co-founder of Optionmonster.com and frequent guest on CNBC's "Fast Money."
"The retailer based in Arkansas had a director that bought 100,000 shares the other day," Najarian said. "That's a big investment...and institutions have been coming back, as this sounded the all-clear after the stock had sold off from about 38 down to 17."
Najarian said unusual buying "implies that people are looking for some good upside in the near term."
He also sees heavy institutional buying in the iShares MSCI Japan Index, and in Abbott Laboratories. On Thursday, a Food and Drug Administration panel voted to recommend approval of a drug-coated stent made by Abbott and Boston Scientific.